Continuous Positive Airway Pressure Ventilation After Acute Ischemic Stroke
Primary Purpose
Brain Infarction
Status
Completed
Phase
Phase 1
Locations
Germany
Study Type
Interventional
Intervention
non-invasive continuous positive airway pressure ventilation
CPAP-treatment
Sponsored by
About this trial
This is an interventional treatment trial for Brain Infarction focused on measuring ischemic stroke, CPAP ventilation
Eligibility Criteria
Inclusion criteria: AGE 18-85 years, NIH-SS 2-20 points, NIH-SS subitem 1a <=1. Exclusion criteria: Modified Rankin Scale Score >=2 on admission primary intubation, Congestive heart failure (NYHA >=3), respiratory insufficiency recurrent vomiting absence of gag reflex, participation in another RCT for the ultrasound sub-study absence of temporal bone window for insonation stenosis or occlusion of major brain supplying arteries interfering with normal blood flow
Sites / Locations
- University_Hospital_Muenster
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
A
B
Arm Description
treatment with three nights of CPAP ventilation starting the first night of admission
usual Stroke Unit care
Outcomes
Primary Outcome Measures
Primary endpoint is to test the feasibility of early non-invasive CPAP ventilation in acute stroke patients
Secondary Outcome Measures
Size of brain infarction on diffusion weighted MRI imaging at day 10 after symptom onset
Disability measured by the modified Rankin scale after three months
Full Information
NCT ID
NCT00151177
First Posted
September 7, 2005
Last Updated
November 23, 2010
Sponsor
University Hospital Muenster
Collaborators
New Health Sciences, Inc., Rubel GmbH, Heiligenhaus, Germany
1. Study Identification
Unique Protocol Identification Number
NCT00151177
Brief Title
Continuous Positive Airway Pressure Ventilation After Acute Ischemic Stroke
Official Title
Feasibility and Efficacy Study of Early Continuous Positive Airway Pressure Ventilation in Patients With Acute Ischemic Stroke
Study Type
Interventional
2. Study Status
Record Verification Date
April 2008
Overall Recruitment Status
Completed
Study Start Date
April 2005 (undefined)
Primary Completion Date
January 2008 (Actual)
Study Completion Date
April 2008 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
University Hospital Muenster
Collaborators
New Health Sciences, Inc., Rubel GmbH, Heiligenhaus, Germany
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
More than half of all stroke patients have sleep apneas in the acute phase after stroke. Sleep apneas may be associated with higher degrees of disability three months after stroke due to numerous factors associated with sleep apneas such as persistent hypertension, cardiac arrhythmias, and clotting disorders.
Non-invasive CPAP (continuous positive airway pressure)-therapy may reverse a number of these effects very shortly after initiation. The aim of the study is to test the feasibility of early non-invasive CPAP treatment starting in the first night after stroke onset, and to test its efficacy in a randomized clinical trial.
50 patients with acute ischemic stroke will be enrolled and randomly assigned to standard care PLUS CPAP treatment or standard care only. All patients randomized to the intervention group will receive CPAP therapy for the first three nights after stroke. In the fourth night, a cardiorespiratory polygraphy will be performed in patients and controls. Patients assigned to the intervention group with a respiratory distress index > 10/h will be treated further on. On admission, day 4, and day 10 after stroke, diffusion weighted MRI imaging will be performed to determine the size of the infarction. The NIHSS score will be used to assess clinical short-term outcome on day 4 and day 10. After three months, the outcome will be determined using the modified Rankin scale.
As CPAP therapy may be more laborious for the provider, the additional work-load will be documented using pre-specified scales.
Primary hypothesis of the study is, that CPAP therapy is feasible in acute stroke patients and that the additional work load will not outweigh the benefits.
Secondary hypothesis is that patients assigned to the treatment group have smaller infarctions on MRI and less neurological deficits at 3 months after stroke.
Patients entering the study will be investigated by transcranial Doppler ultrasound in case they have sufficient temporal bone windows for insonation and no stenosis or occlusions of major brain supplying arteries by the time of investigation that disturb the intracerebral blood flow.
All intracranial arteries will be assessed before treatment, after treatment and on day 8 after the insult.
Screen shots will be taken and will be analysed by dynamic vascular ultrasound (DVA), a new software algorithm developed by NHSi, to investigate microcirculatory information from the flow spectra of the major intracranial arteries.
The data from this post-hoc analysis are compared with the data of the polysomnography and with treatment.
Primary hypothesis in this substudy is that DVA reliably identifies patients with sleep apnea on days one and four after stroke. Secondary hypothesis is that DVA can distinguish between treated patients and controls.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Brain Infarction
Keywords
ischemic stroke, CPAP ventilation
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
A
Arm Type
Experimental
Arm Description
treatment with three nights of CPAP ventilation starting the first night of admission
Arm Title
B
Arm Type
No Intervention
Arm Description
usual Stroke Unit care
Intervention Type
Device
Intervention Name(s)
non-invasive continuous positive airway pressure ventilation
Intervention Type
Device
Intervention Name(s)
CPAP-treatment
Intervention Description
night time CPAP-mask ventilation
Primary Outcome Measure Information:
Title
Primary endpoint is to test the feasibility of early non-invasive CPAP ventilation in acute stroke patients
Secondary Outcome Measure Information:
Title
Size of brain infarction on diffusion weighted MRI imaging at day 10 after symptom onset
Title
Disability measured by the modified Rankin scale after three months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
AGE 18-85 years,
NIH-SS 2-20 points,
NIH-SS subitem 1a <=1.
Exclusion criteria:
Modified Rankin Scale Score >=2 on admission
primary intubation,
Congestive heart failure (NYHA >=3),
respiratory insufficiency
recurrent vomiting
absence of gag reflex,
participation in another RCT
for the ultrasound sub-study
absence of temporal bone window for insonation
stenosis or occlusion of major brain supplying arteries interfering with normal blood flow
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Darius G Nabavi, MD
Organizational Affiliation
University Hospital Muenster
Official's Role
Principal Investigator
Facility Information:
Facility Name
University_Hospital_Muenster
City
Muenster
ZIP/Postal Code
48129
Country
Germany
12. IPD Sharing Statement
Citations:
PubMed Identifier
12154259
Citation
Turkington PM, Bamford J, Wanklyn P, Elliott MW. Prevalence and predictors of upper airway obstruction in the first 24 hours after acute stroke. Stroke. 2002 Aug;33(8):2037-42. doi: 10.1161/01.str.0000023576.94311.27.
Results Reference
background
PubMed Identifier
9303023
Citation
Bassetti C, Aldrich MS, Quint D. Sleep-disordered breathing in patients with acute supra- and infratentorial strokes. A prospective study of 39 patients. Stroke. 1997 Sep;28(9):1765-72. doi: 10.1161/01.str.28.9.1765.
Results Reference
background
PubMed Identifier
11914407
Citation
Iranzo A, Santamaria J, Berenguer J, Sanchez M, Chamorro A. Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology. 2002 Mar 26;58(6):911-6. doi: 10.1212/wnl.58.6.911.
Results Reference
background
PubMed Identifier
22198979
Citation
Minnerup J, Ritter MA, Wersching H, Kemmling A, Okegwo A, Schmidt A, Schilling M, Ringelstein EB, Schabitz WR, Young P, Dziewas R. Continuous positive airway pressure ventilation for acute ischemic stroke: a randomized feasibility study. Stroke. 2012 Apr;43(4):1137-9. doi: 10.1161/STROKEAHA.111.637611. Epub 2011 Dec 22.
Results Reference
derived
Learn more about this trial
Continuous Positive Airway Pressure Ventilation After Acute Ischemic Stroke
We'll reach out to this number within 24 hrs